Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Pharmacogenomics. 2015;16(3):273–285. doi: 10.2217/pgs.14.170

Figure 2. Outline of using in vitro human cell line models to predict clinical response to anticancer therapy.

Figure 2

This flow diagram outlines the strategy of how to use an in vitro human cell line model to predict clinical response.

GWAS: Genome-wide association study;

LCL: Lymphoblastoid cell line.